Continuation of concomitant medical products: product id 8709, lot# j11176r58, serial# (b)(4), implanted:(b)(6) 2002, product type: catheter , ubd: 22-apr-2004, udi#: (b)(4).
If information is provided in the future, a supplemental report will be issued.
|
On (b)(6) 2022, information was received from two healthcare professionals (hcp), via a manufacturer representative (rep), regarding a patient receiving gablofen (2,000 mcg/ml, 300 mcg/day) via an implantable pump.
The patient's other medications were methylphenidate, tegretol, lexapro, baclofen prn.
The patient's medical history includes; traumatic brain injury with spastic quadriparesis, nystagmus, myopia, exposure keratopathy left, and dysarthria, suspension, vision impairment, posttraumatic hydrocephalus, wheelchair-bound, itb pump.
It was reported the patient was originally implanted at another clinic and started to be managed by another clinic in (b)(6) 2021.
The patient was scheduled for pump expected ended of life battery replacement.
Routine access to the catheter access port (cap) was done in anticipation and upon replacement and the clinician was unable to withdraw cerebrospinal fluid (csf) back from the cap on (b)(6) 2022.
The patient never exhibited any signs or symptoms of baclofen withdrawal nor loss of therapy efficacy.
A catheter exploration and pump replacement was scheduled for (b)(6) 2022.
The issue was not resolved at the time of this report.
Additional information reported the pump has been refilled four times since the new clinic started managing the pump.
The expected versus residual volumes were accurate at these four refills.
|